Dentists in Crete, NE Accepting Medicare
7 Dentists found. Showing 1 - 7
 Zachary John Keating, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1304 Kingwood Ave, Crete, NE 68333 Phone: 402-826-2645 |
Nicholas Jon Dierks Dentist Medicare: Not Enrolled in Medicare Practice Location: 130 E 13th St, Crete, NE 68333 Phone: 402-826-4302 |
Dr. Howard Leon Doty, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 130 E 13th St, Crete, NE 68333 Phone: 402-826-4302 |
Dr. John Fischer, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 307 E 12th St, Crete, NE 68333 Phone: 402-826-1015 |
Dr. Richard John Jirovec, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1304 Kingwood Ave, Crete, NE 68333 Phone: 402-826-2645 |
Dr. James Edward Jirovec, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1304 Kingwood Ave, Crete, NE 68333 Phone: 402-826-2645 |
Dr. Bruce Orval Kennedy, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1117 Main Ave, Crete, NE 68333 Phone: 402-826-2488 Fax: 402-826-4752 |
News Archive
Leading advocates join together to call for passage of legislation in the House
Today, leading advocates for seniors, military families and physicians joined together to call for passage of legislation in the House that will preserve access to care for seniors, baby boomers and military families through repeal of the broken Medicare physician payment formula.
New piece found in colorectal cancer puzzle
Prostasin, a relatively unknown protease enzyme expressed in most epithelial cells, may play a role in the genesis of colorectal cancer. Researchers writing in the open access journal BMC Cancer have associated a reduction in the expression of inhibitors of the enzyme with malignant cellular behavior.
Inviragen commences Phase 1 clinical trial of DENVax dengue vaccine in Colombia
Inviragen, a company developing vaccines to protect against infectious diseases worldwide, and the Program for the Study and Control of Tropical Diseases (PECET), jointly announced the initiation of a Phase 1 clinical trial of DENVax™ in Colombia. DENVax is an investigational vaccine designed to provide protection against all four dengue virus serotypes. The trial will measure the safety of DENVax as well as the immune responses induced by the vaccine in healthy adults in Rionegro, Colombia.
Advaxis to update preliminary data on ADXS-HPV Phase 2 trial for cervical cancer
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
Rare immune cells found to play a major role in lasting immunity
According to the latest research from the Walter and Eliza Hall Institute the characterization of a rare immune cell's involvement in antibody production and ability to ‘remember' infectious agents could help to improve vaccination and lead to new treatments for immune disorders.
› Verified 1 days ago